Today, the 50 leading companies-for-the-future in Techarenan Challenge 2021 is released officially. Companies from all over the Nordic region have applied for the competition and the finalists are active in a number of different industries. The companies compete for the coveted titles “Startup company of the year”, “Growth company of the year” and “Social Impact Award”.
The companies have been evaluated by an expert jury with a focus on scalability, sustainability and that there are well-defined growth opportunities.
BioReperia is a medtech company with an innovative model to evaluate anti-cancer drugs. Our model could reduce cancer mortality by predicting the most efficient cancer treatments for each individual patient within a week, using a Zebrafish Tumour Xenograft platform, meaning an opportunity to give right treatment for the right patient! (https://bioreperia.com/for-clincial-providers/)
BioReperia will participate in one out of two finals, the one that will be organized in Stockholm (Berns) in November. During the final days, the companies will pitch on site for this year’s jury. Panels and news broadcasts are arranged on the subject of innovation, entrepreneurship, sustainability and the future.
We in the BioReperia team are very happy and proud for being in this exclusive final and look forward to presenting our innovation in Stockholm in November! For more information; https://bioreperia.com/news/